- August 28, 2018 Spero Therapeutics to Present New Data for SPR994 and SPR206 at ESCMID/ASM 2018 Conference
- August 14, 2018 Spero Announces Appointment of John C. Pottage, Jr., MD to its Board of Directors
- August 09, 2018 Spero Therapeutics Announces Second Quarter 2018 Financial Results and Pipeline Overview
- July 16, 2018 Spero Awarded up to $54 Million by BARDA and DTRA to Support SPR994 Development
- July 12, 2018 Spero Therapeutics Announces Pricing of Securities Offering
- July 09, 2018 Spero Therapeutics Announces Proposed Offering of Common Stock
- July 09, 2018 Spero Announces Positive Interim Phase 1 SAD/MAD Results for SPR994
- June 05, 2018 Spero Therapeutics to Present New Preclinical Data for SPR994 at ASM Microbe 2018
- June 01, 2018 Spero Therapeutics to Present at the Jefferies 2018 Healthcare Conference in June
- May 23, 2018 Spero Therapeutics Announces Positive Top-Line Data for Two Product Candidates from its Potentiator Platform
Displaying 11 - 20 of 72 results